Best-in-class compound identified via best-in-class profiling method. Maybe not a coincidence.
501 followers
157 followers
Congratulations to Repare on the progress shown for the ATR inhibitor camonsertib (RP-3500) in the clinic. Selectivity of RP-3500 was determined on KiNativ (https://t.co/nbwOuC0cS4)
4,124 followers
RT @MCT_AACR: Targeting ATR is being investigated as an approach to treating the many cancers that have DNA repair pathway defects. RP-3500…
1,344 followers
Targeting ATR is being investigated as an approach to treating the many cancers that have DNA repair pathway defects. RP-3500 is novel ATR inhibitor shown to be effective at reducing tumor growth in several preclinical models of cancer. https://t.co/UaSAj3